Resolution of the Expert council «Iron-deficiency anemia»

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article presents the Resolution of the Expert council «Iron-deficiency anemia».

全文:

受限制的访问

作者简介

A. Martynov

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

编辑信件的主要联系方式.
Email: abramova@bionika-media.ru

MD, Professor, Academician of RAS, Professor of the Department of Hospital Therapy No. 1 of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, president of Russian Scientific Medical Society of Internal Medicine (RSMSIM)

俄罗斯联邦, Moscow

A. Malyavin

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

Email: abramova@bionika-media.ru

MD, Professor, Professor of the Department of Phthisiology and Pulmonology of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, Chief Freelance Pulmonologist of the Ministry of Healthcare of Russia in the Central Federal District, Secretary General of RSMSIM

俄罗斯联邦, Moscow

E. Lukina

National Medical Research Center for Hematology of the Ministry of Healthcare of Russia

Email: abramova@bionika-media.ru

MD, Professor, Head of the Department of Orphan Diseases, Hematologist of the Highest Category

俄罗斯联邦, Moscow

N. Stuklov

Peoples’ Friendship University of Russia

Email: abramova@bionika-media.ru

MD, Professor, Hematologist, Head of the Course of Hematology of the Department of Hospital Therapy with Courses of Endocrinology, Hematology and Clinical Laboratory Diagnostics of the Faculty of Medicine

俄罗斯联邦, Moscow

O. Khlynova

Academician E.A. Wagner Perm State Medical University of the Ministry of Healthcare of Russia

Email: abramova@bionika-media.ru

MD, Professor, Corresponding Member of RAS, Gastroenterologist, Head of the Department of Hospital Therapy of Academician E.A. Wagner Perm State Medical University of the Ministry of Healthcare of Russia, Doctor of the Highest Category

俄罗斯联邦, Perm

M. Vinogradova

Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia

Email: abramova@bionika-media.ru

PhD in Medical Sciences, Hematologist, Associate Professor of the Department of Hematology and Transfusiology of Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia, member of European Hematology Association (EHA), International Society of Thrombosis and Hemostasis (ISTH), American Society of Hematology (ASH)

俄罗斯联邦, Moscow

T. Zefirova

Kazan State Medical Academy – a branch of Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia

Email: abramova@bionika-media.ru

MD, Professor of the Department of Obstetrics and Gynecology No. 1

俄罗斯联邦, Kazan

参考

  1. Ивакина С.Н., Нагимова Г.М., Бакиров Б.А., Кудлай Д.А. Анализ применения железосодержащих лекарственных препаратов для лечения анемии в России. Профилактическая медицина. 2021; 24(4): 13–22. [Ivakina S.N., Nagimova G.M., Bakirov B.A., Kudlay D.A. Analysis of the iron-containing drugs’ application for the treatment of anemia in Russia. Profilakticheskaya meditsina = The Russian Journal of Preventive Medicine. 2021; 24(4): 13–22 (In Russ.)]. https://dx.doi.org/10.17116/profmed20212404113. EDN: CIMMWZ.
  2. Здравоохранение в России. 2021: статистический сборник. М.: Росстат. 2021; 171 с. Доступ: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf (дата обращения – 01.06.2023). [Healthcare in Russia. 2021: statistical compendium. Moscow: Federal State Statistics Service (Russia). 2021; 171 pp. URL: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf (date of access – 01.06.2023) (In Russ.)].
  3. Драпкина О.М., Мартынов А.И., Байда А.П. с соавт. Резолюция экспертного совета «Актуальные вопросы железодефицита в Российской Федерации». Кардиоваскулярная терапия и профилактика. 2020; 19(5): 236–241. [Drapkina O.M., Martynov A.I., Baida A.P. et al. Resolution of the expert council «Relevant issues of iron deficiency in the Russian Federation». Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2020; 19(5): 236–241 (In Russ.)]. https://dx.doi.org/10.15829/1728-8800-2020-2700. EDN: TBBFGZ.
  4. Клинические рекомендации. Железодефицитная анемия. Национальное гематологическое общество, Национальное общество детских гематологов, онкологов. Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 669. Доступ: https://cr.minzdrav.gov.ru/schema/669_1 (дата обращения – 01.06.2023). [Clinical guidelines. Iron-deficiency anemia. National Hematological Society, National Society of Pediatric Hematologists, Oncologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2021. ID: 669. URL: https://cr.minzdrav.gov.ru/schema/669_1 (date of access – 01.06.2023) (In Russ.)].
  5. Pavord S., Daru J., Prasannan N. et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2020; 188(6): 819–30. https://dx.doi.org/10.1111/bjh.16221.
  6. Stoffel N.U., Zeder C., Brittenham G.M. et al. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020; 105(5): 1232–39. https://dx.doi.org/10.3324/haematol.2019.220830.
  7. Тютюнник В.Л., Кан Н.Е., Михайлова О.И. Коррекция железодефицитной анемии у беременных. Акушерство и гинекология. 2018; (8): 106–110. [Tyutyunnik V.L., Kan N.E., Mikhailova O.I. Correction of iron-deficiency anemia in pregnant women. Akusherstvo i ginekologiya = Obstetrics and Gynecology. 2018; (8): 106–110 (In Russ.)]. https://dx.doi.org/10.18565/aig.2018.8.106-110. EDN: YAHEFF.
  8. Государственный реестр лекарственных средств Минздрава России. Инструкция по медицинскому применению лекарственного препарата Ферро-Фольгамма Нео®. РУ: ЛП-№(000586)-(РГ-RU). Доступ: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=4ab025df-3559-4e57-b90f-3bf16144be47 (дата обращения – 01.06.2023). [State Register of Medicines of the Ministry of Healthcare of Russia. Ferro-Folgamma Neo®. Patient information leaflet. Registration certificate: ЛП-№(000586)-(РГ-RU). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=4ab025df-3559-4e57-b90f-3bf16144be47 (date of access – 01.06.2023) (In Russ.)].
  9. Государственный реестр лекарственных средств Минздрава России. Инструкция по медицинскому применению лекарственного препарата Сорбифер Дурулес. РУ: ЛП-N (000080)-(РГ-RU). Доступ: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8ba0382b-86d4-4768-8891-9c3d3dba435f (дата обращения – 01.06.2023). [State Register of Medicines of the Ministry of Healthcare of Russia. Ferro-Folgamma Neo. Patient information leaflet. Registration certificate: ЛП-N (000080)-(РГ-RU). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8ba0382b-86d4-4768-8891-9c3d3dba435f (date of access – 01.06.2023) (In Russ.)].
  10. D’Adamo C.R., Novick J.S., Feinberg T.M. et al. A food-derived dietary supplement containing a low dose of iron improved markers of iron status among nonanemic iron-deficient women. J Am Coll Nutr. 2018; 37(4): 342–49. https://dx.doi.org/10.1080/07315724.2018.1427158.
  11. Pasricha S.R., Tye-Din J., Muckenthaler M.U., Swinkels D.W. Iron deficiency. Lancet. 2021; 397(10270): 233–48. https://dx.doi.org/10.1016/S0140-6736(20)32594-0.
  12. Государственный реестр лекарственных средств Минздрава России. Инструкция по медицинскому применению лекарственного препарата Тардиферон®. РУ: ЛП-№(000332)-(РГ-RU). Доступ: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=49b438bb-9df9-4a79-8b07-89a5a4208c02 (дата обращения – 01.06.2023). [State Register of Medicines of the Ministry of Healthcare of Russia. Tardyferon®. Patient information leaflet. Registration certificate: ЛП-№(000332)-(РГ-RU). URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=49b438bb-9df9-4a79-8b07-89a5a4208c02 (date of access – 01.06.2023) (In Russ.)].
  13. Moretti D., Goede J.S., Zeder C. et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015; 126(17): 1981–89. https://dx.doi.org/10.1182/blood-2015-05-642223.
  14. Rimon E., Kagansky N., Kagansky M. et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005; 118(10): 1142–47. https://dx.doi.org/10.1016/j.amjmed.2005.01.065.
  15. Доброхотова Ю.Э., Каранашева А.Х. Антианемическая терапия у больных с субмукозной миомой матки после эмболизации маточных артерий. Лечебное дело. 2021; (4): 52–56. [Dobrochotova Yu.E., Karanasheva A.Kh. Antianemic treatment of patients with submucosal uterine myoma after uterine artery embolization. Lechebnoye delo = General Medicine. 2021; (4): 52–56 (In Russ.)]. https://dx.doi.org/10.24412/2071-5315-2021-12393. EDN: CYDKIT.
  16. Государственный реестр лекарственных средств Минздрава России. Инструкция по медицинскому применению лекарственного препарата Гино-Тардиферон®. РУ: ЛС-000300. Доступ: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=e528be41-33a0-4036-a3c3-61f4bc249b46 (дата обращения – 01.06.2023). [State Register of Medicines of the Ministry of Healthcare of Russia. Gyno-Tardyferon®. Patient information leaflet. Registration certificate: ЛС-000300. URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=e528be41-33a0-4036-a3c3-61f4bc249b46 (date of access – 01.06.2023) (In Russ.)].
  17. Бертумье Д., Дюпине П., Трануа Ф. Композиция с пролонгированным высвобождением активного вещества, способ ее получения и применение. Патент №2414211. Доступ: https://patents.google. com/patent/RU2414211C2/ru (дата обращения – 26.06.2023). [Berthumier D., Dupinet P., Tranoy F. Composition with prolonged release of the active substance, method of its preparation and use. Patent №2414211. URL: https://patents.google. com/patent/RU2414211C2/ru (date of access – 26.06.2023) (In Russ.)].
  18. Лебедев В.В., Демихов В.Г., Дмитриев А.В. с соавт. Сравнительная эффективность и безопасность применения препаратов двух- и трехвалентного железа для лечения железодефицитной анемии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2016; 15(4): 5–12. [Lebedev V.V., Demikhov V.G., Dmitriev A.V. et al. A comparative efficacy and safety of using ferrous and ferric iron preparations for management of iron-deficiency anaemia. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Haematology/Oncology and Immunopathology. 2016; 15(4): 5–12 (In Russ.)]. https://dx.doi.org/10.20953/1726-1708-2016-4-5-12. EDN: YIJLCZ.
  19. Зефирова Т.П., Мухаметова Р.Р., Хаертдинов А.Т., Гарипова Э.М. Опыт применения комбинированного препарата железа и фолиевой кислоты для коррекции латентного дефицита железа в клинической практике акушера-гинеколога. Гинекология. 2023; 25(2). [Zefirova T.P., Mukhametova R.R., Khaertdinov A.T., Garipova E.M. Experience in the use of a combined preparation of iron and folic acid for the correction of latent iron deficiency in the clinical practice of an obstetrician-gynecologist. Ginekologiya = Gynecology. 2023; 25(2) (In Russ.)]. https://dx.doi.org/10.26442/20795696.2023.2.202223.
  20. Lane D.J., Richardson D.R. The active role of vitamin C in mammalian iron metabolism: Much more than just enhanced iron absorption! Free Radic Biol Med. 2014; 75: 69–83. https://dx.doi.org/10.1016/j.freeradbiomed.2014.07.007.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2023
##common.cookie##